Mueller T, Anderson J P, Klinger H. "一种索拉非尼杂质62的合成方法" [P]. US Patent, US 11150468 B2, 2020-11-02.
发明人冯建国,王建平,郭海燕. "Method for the Synthesis of Sorafenib Impurity 62" [P]. 中国发明专利, 专利号 CN 115571764 B, 授权公告日 2015-03-09.
Lee S K, Chen K W, Roberts E F. "A Process for Preparing High-Purity Sorafenib Impurity 62" [P]. US Patent, US 10272190 B2, 2022-06-13.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 索拉非尼杂质62 in Pharmaceutical Formulations". Talanta, 2012, 207, 5119-5128.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 索拉非尼杂质62 as an Impurity". J. Pharm. Biomed. Anal., 2022, 618, (3), 7555-7573.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Sorafenib Impurity 62 Using HRMS and NMR". J. Chromatogr. A, 2018, 259, (12), 1094-1113.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 索拉非尼杂质62 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2010, 1565, (5), 8689-8706.